---
title: "SSSW reported a net loss of 2.0659 million yuan for the year 2024"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/229877480.md"
description: "According to the Zhitong Finance APP, SSSW released its 2024 annual performance preliminary report. During the reporting period, the company achieved total operating revenue of 350 million yuan, a year-on-year decrease of 13.28%; realized a net loss attributable to the owners of the parent company of 2.0659 million yuan; and realized a net loss attributable to the owners of the parent company after deducting non-recurring gains and losses of 73.0057 million yuan"
datetime: "2025-02-27T08:44:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/229877480.md)
  - [en](https://longbridge.com/en/news/229877480.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/229877480.md)
generator: "portal-rs"
---

# SSSW reported a net loss of 2.0659 million yuan for the year 2024

According to the Zhitong Finance APP, SSSW (688399.SH) released its performance preliminary report for the year 2024. During the reporting period, the company achieved total operating revenue of 350 million yuan, a year-on-year decrease of 13.28%; it recorded a net loss attributable to the owners of the parent company of 2.0659 million yuan; and a net loss attributable to the owners of the parent company after deducting non-recurring gains and losses of 73.0057 million yuan

### Related Stocks

- [688399.CN](https://longbridge.com/en/quote/688399.CN.md)

## Related News & Research

- [09:10 ETLAIKA and Big Brothers Big Sisters of Greater Los Angeles Launch National "Wildwood Heroes" Campaign Celebrating Courage Beyond the Screen](https://longbridge.com/en/news/297920335.md)
- [Biohit says scientific review backs serum biomarker triage to target endoscopy for gastric cancer risk](https://longbridge.com/en/news/297887371.md)
- [10:33 ETUniphi Space Agency Is Now The Astronaut Agency -- A Bold New Name for the World's Leading Astronaut Speakers Bureau](https://longbridge.com/en/news/297801849.md)
- [NeuroGT Announces FDA Clearance of Investigational New Drug Application for NGT-104, an AAV9 Gene Replacement Product for MPS IIIB](https://longbridge.com/en/news/297947685.md)
- [Cleo Diagnostics to Commence Analytical Validation of Pre-Surgical Ovarian Cancer Blood Test](https://longbridge.com/en/news/297848437.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**